NexGel, Inc. (NXGL)
1.16
+0.05
(+4.50%)
USD |
NASDAQ |
Feb 26, 11:44
NexGel Research and Development Expense (Quarterly) : 0.007M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| The Cooper Cos., Inc. | 41.40M |
| STAAR Surgical Co. | 9.009M |
| OrthoPediatrics Corp. | 2.333M |
| Innovative Eyewear, Inc. | 0.13M |
| Plus Therapeutics, Inc. | 2.436M |